Aptinyx Inc 's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Aptinyx Inc 's ROA in the first quarter of 2023?
Aptinyx Inc recorded a cumulative net loss of $-66 million during 12 months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -93.56%.

However, within the Healthcare sector 961 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2023 quarter, so far to 5134, from total ROA ranking in the fourth quarter of 2022 at 5777.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter
Y / Y Total Assets Change	-55.03 %	-42.52 %	-42.55 %	-31.2 %	-30.24 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-66	-65	-72	-78	-80
Return On Assets (TTM)	-93.56 %	-76.02 %	-74.25 %	-70.17 %	-65.92 %
APTX's Total Ranking	# 5134	# 5777	# 5112	# 5226	# 5145
Total Assets (TTM) in million	48	66	76	92	107
Seq. Total Assets Change	-27.4 %	-13.31 %	-17.44 %	-13.45 %	-7.2 %
Seq. Net Income Change	-	-	-	-	-

APTX's 5 Years Annual ROA >> Back to APTX Management Effectiveness >> Compare APTX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 459
Sector	# 962
Overall	# 5025

Return On Assets Statistics
High	Average	Low
-36.78 %	-53.95 %	-93.36 %
(Mar 31 2021)		(Mar 31 2023)

Financial Statements
Aptinyx Inc 's Assets	$ 48 million	APTX's Balance sheet
Aptinyx Inc 's Income	$ -21 million	Quarterly APTX's Income Statement
APTX's Income by Division		See APTX's Income by Division

Annual Return On Assets	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2017) FY 2018
Y / Y Total Assets Change	-42.52 %	-23.69 %	-1.26 %	56.33 %	-
Total Assets in million	66	115	151	153	98
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-65	-75	-50	-57	-32
Annual Return On Assets	-98.16 %	-65.16 %	-33.23 %	-37.64 %	-32.87 %

APTX's 5 Years Annual ROA >> Back to APTX Management Effectiveness >> Compare APTX ROA to its Competitors

More Return On Assets Ratios
APTX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
APTX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for APTX's Competitors
Subscribers only: Roa for Aptinyx Inc 's Suppliers
Subscribers only: Return On Assets for APTX's Customers

You may also want to know
APTX's Roi	APTX's Inventory Turnover Ratio	APTX's Growth Rates	APTX's Dividend Comparisons
	APTX's Profitability Ratios	APTX's Asset Turnover Ratio	APTX's Dividend Growth
APTX's Roe	APTX's Valuation Ratios	APTX's Financial Strength Ratios	APTX's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2023, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:10:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.